Diseases Market Research Reports

Medical Diseases Market Research Reports, Analysis & Trends

 
Publication Single User License (PDF) Price
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015’, provides an overview of the Secondary Progressive Multiple Sclerosis (SPMS)’s therapeutic pipeline.

$2,000.00
Primary Biliary Cirrhosis - Pipeline Review, H1 2015

Primary Biliary Cirrhosis - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Primary Biliary Cirrhosis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Primary Biliary Cirrhosis - Pipeline Review, H1 2015’, provides an overview of the Primary Biliary Cirrhosis’s therapeutic pipeline.

$2,000.00
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic pipeline.

$2,000.00
Biliary Cirrhosis - Pipeline Review, H1 2015

Biliary Cirrhosis - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Biliary Cirrhosis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Biliary Cirrhosis - Pipeline Review, H1 2015’, provides an overview of the Biliary Cirrhosis’s therapeutic pipeline.

$2,000.00
Polycystic Ovarian Syndrome - Pipeline Review, H1 2015

Polycystic Ovarian Syndrome - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Polycystic Ovarian Syndrome - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Polycystic Ovarian Syndrome - Pipeline Review, H1 2015’, provides an overview of the Polycystic Ovarian Syndrome’s therapeutic pipeline.

$2,000.00
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015’, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)’s therapeutic pipeline.

$2,000.00
Tardive Dyskinesia - Pipeline Review, H1 2015

Tardive Dyskinesia - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Tardive Dyskinesia - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Tardive Dyskinesia - Pipeline Review, H1 2015’, provides an overview of the Tardive Dyskinesia’s therapeutic pipeline.

$2,000.00
Asthma - Pipeline Review, H1 2015

Asthma - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Asthma - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2015’, provides an overview of the Asthma’s therapeutic pipeline.

$2,500.00
Peritoneal Cancer - Pipeline Review, H1 2015

Peritoneal Cancer - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Peritoneal Cancer - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2015’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline.

$2,000.00
Constipation - Pipeline Review, H1 2015

Constipation - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Constipation - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Constipation - Pipeline Review, H1 2015’, provides an overview of the Constipation’s therapeutic pipeline.

$2,000.00
Myasthenia Gravis - Pipeline Review, H1 2015

Myasthenia Gravis - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Myasthenia Gravis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H1 2015’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline.

$2,000.00
Ulcerative Colitis - Pipeline Review, H1 2015

Ulcerative Colitis - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Ulcerative Colitis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2015’, provides an overview of the Ulcerative Colitis’s therapeutic pipeline.

$2,000.00
Diarrhea - Pipeline Review, H1 2015

Diarrhea - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Diarrhea - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Diarrhea - Pipeline Review, H1 2015’, provides an overview of the Diarrhea’s therapeutic pipeline.

$2,000.00
Influenza B Infections - Pipeline Review, H1 2015

Influenza B Infections - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Influenza B Infections - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Influenza B Infections - Pipeline Review, H1 2015’, provides an overview of the Influenza B Infections’s therapeutic pipeline.

$2,000.00
Status Epilepticus - Pipeline Review, H1 2015

Status Epilepticus - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Status Epilepticus - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Status Epilepticus - Pipeline Review, H1 2015’, provides an overview of the Status Epilepticus’s therapeutic pipeline.

$2,000.00
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015’, provides an overview of the Spinal Muscular Atrophy (SMA)’s therapeutic pipeline.

$2,000.00
Metastatic Prostate Cancer - Pipeline Review, H1 2015

Metastatic Prostate Cancer - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Metastatic Prostate Cancer - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Metastatic Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Prostate Cancer’s therapeutic pipeline.

$2,000.00
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2015

Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2015’, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome)’s therapeutic pipeline.

$2,000.00
Glaucoma - Pipeline Review, H1 2015

Glaucoma - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Glaucoma - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Glaucoma - Pipeline Review, H1 2015’, provides an overview of the Glaucoma’s therapeutic pipeline.

$2,000.00
Sarcopenia - Pipeline Review, H1 2015

Sarcopenia - Pipeline Review, H1 2015

Date Published: Jan 22 2015

Sarcopenia - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Sarcopenia - Pipeline Review, H1 2015’, provides an overview of the Sarcopenia’s therapeutic pipeline.

$2,000.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data